Stem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005-01 trial.
Moreau
P
P
Hulin
C
C
Marit
G
G
Caillot
D
D
Facon
T
T
Lenain
P
P
Berthou
C
C
Pégourié
B
B
Stoppa
A M
AM
Casassus
P
P
Michallet
M
M
Benboubker
L
L
Maisonneuve
H
H
Doyen
C
C
Leyvraz
S
S
Mathiot
C
C
Avet-Loiseau
H
H
Attal
M
M
Harousseau
J L
JL
D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D003907:Dexamethasone / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D019650:Hematopoietic Stem Cell Mobilization; D006412:Hematopoietic Stem Cells; D006801:Humans; D007937:Leukapheresis / Q000379:methods*; D009101:Multiple Myeloma / Q000628:therapy*; D011719:Pyrazines / Q000627:therapeutic use*; D033581:Stem Cell Transplantation; D014182:Transplantation, Autologous
D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone